Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro

Design, synthesis, and biological evaluation of new 2′-deoxy-2′-fluoro-4′-triazole cytidine nucleosides as potent antiviral agents

(2013) Jie Wu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs

(2013) Xing-Jie Zhang et al.   PLoS One

Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant hepatitis B virus clinical isolates

(2012) Yubing Zhou et al.   ANTIVIRAL THERAPY

Antiviral activity of FNC, 2′-deoxy-2′-β-fluoro-4′-azidocytidine, against human and duck HBV replication

(2012) Liyun Zheng et al.   ANTIVIRAL THERAPY

Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities

(2012) Francesco Scaglione et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors

(2012) P. L. Boyer et al.   JOURNAL OF VIROLOGY

HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism

(2012) Kalyan Das et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

A Comprehensive Mapping of HIV-1 Genotypes in Various Risk Groups and Regions across China Based on a Nationwide Molecular Epidemiologic Survey

(2012) Xiang He et al.   PLoS One

F18, a Novel Small-Molecule Nonnucleoside Reverse Transcriptase Inhibitor, Inhibits HIV-1 Replication Using Distinct Binding Motifs as Demonstrated by Resistance Selection and Docking Analysis

(2011) Xiaofan Lu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells

(2011) Qiang Wang et al.   BIOCHEMICAL PHARMACOLOGY

Synthesis of new 2′-deoxy-2′-fluoro-4′-azido nucleoside analogues as potent anti-HIV agents

(2011) Qiang Wang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Near Full-Length Genomic Characterization of a Novel HIV Type 1 Subtype B/C Recombinant Strain from Yunnan, China

(2010) Lin Li et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir

(2010) Douglas Barnas et al.   ANTIVIRAL THERAPY

Protein Kinases: Docking and Homology Modeling Reliability

(2010) Tiziano Tuccinardi et al.   Journal of Chemical Information and Modeling

Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation

(2010) Vici Varghese et al.   PLoS One

Sifuvirtide, a potent HIV fusion inhibitor peptide

(2009) Rui-Rui Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

HIV/hepatitis B virus co-infection: current challenges and new strategies

(2009) K. Lacombe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine

(2009) David B. Smith et al.   JOURNAL OF MEDICINAL CHEMISTRY

An overview of the PubChem BioAssay resource

(2009) Yanli Wang et al.   NUCLEIC ACIDS RESEARCH

Real-time quantitative PCR and fast QPCR have similar sensitivity and accuracy with HIV cDNA late reverse transcripts and 2-LTR circles

(2008) Kristine E. Yoder et al.   JOURNAL OF VIROLOGICAL METHODS

Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later

(2008) Christophe Pannecouque et al.   Nature Protocols